Status:
RECRUITING
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Breast Carcinoma
Esophageal Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the ris...
Detailed Description
PRIMARY OBJECTIVES: I. To prospectively collect data on acute and late toxicities (including second malignant neoplasms) in patients treated with proton therapy. II. To collect and store the corresp...
Eligibility Criteria
Inclusion
- All patients scheduled for radiation treatment with protons at UTMDACC are eligible for this protocol
- Patients must sign a study-specific consent form prior to study entry
Exclusion
- Patients who are unable or unwilling to attend the required periodic follow-ups either at M.D. Anderson or at a different site
Key Trial Info
Start Date :
May 27 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT00991094
Start Date
May 27 2005
End Date
December 31 2027
Last Update
January 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030